The Journal of the Drake Biomedical Institute is a biomedical journal distributed entirely over the Internet. The Journal will be maintained online and archived. Its purpose is to promote and facilitate the international exchange of leading information about stem cell studies and treatments, as well as papers about hormone rejuvenation therapy.
The Journal is a peer reviewed publication, meaning all submitted manuscripts are circulated to selected scientists and medical practitioners for review and critique. Suggestions for changes, questions about the findings, or critiques are forwarded to the authors for possible amendment, consideration, or correction. The Journal will be published quarterly or more often if quality manuscripts are submitted.
The Journal of the Drake Biomedical Institute presents reports of current applied technology, that is, current stem cell applications and current treatments with hormonal preparations. Randomized studies are NOT required. What we want to focus on is that something was tried with a patient, and there was a positive result. Many such treatments are worthy of dissemination and discussion even without the normal and customary control group. The patient may serve as his/her own control wherein the patient had a verifiable, demonstrable diagnosis or condition before hand, and after stem cell therapy or hormone rejuvenation therapy, the condition improved as measured by testing, laboratory reports, photographic/video evidence, or otherwise. We consider such treatments to constitute “single patient clinical trials” or in other terms, “patient specific treatments not requiring a clinical trial”.
Although accepting research reports without requiring randomized studies can lead in some instances to medical fraud, this risk is necessary in order to bring to light important new observations concerning the benefits of stem cell therapy and hormonal rejuvenation therapies. And as we have seen in the past, even controlled medical experiments can be fabricated and pass peer review.
The Journal will present reports of detailed patient treatments using stem cell technology or hormone manipulation and replacement. We are in particular interested in the use of hormones such as Human Growth Hormone and testosterone to improve quality of life in later years, and also as a tool for moderating specific diseases.
All articles and issues of the Journal are distributed and archived on this web site for free, as a public service of the Drake Biomedical Institute, and to foster public discussion of treatments and techniques.
